Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
4 studies found for:    19895780 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Minocycline for the Treatment of Early-Phase Schizophrenia
Condition: Negative and Cognitive Symptoms in Schizophrenia
Interventions: Drug: Minocycline;   Drug: Placebo (200 mg/day)
2 Completed The Study of Minocycline for Negative and Cognitive Symptoms in Schizophrenia
Condition: Schizophrenia
Interventions: Drug: minocycline;   Drug: placebo
3 Recruiting Minocycline Augmentation to Clozapine
Conditions: Schizophrenia;   Schizoaffective Disorder
Intervention: Drug: Minocycline
4 Unknown  Evaluating the Efficacy of Adjunctive Minocycline for the Treatment of Bipolar Depression
Conditions: Bipolar Disorder;   Bipolar Depression;   Bipolar I Depression;   Bipolar II Depression
Intervention: Drug: Minocycline

Indicates status has not been verified in more than two years